Anthropic partners for formal verification, Pathos AI raises $237M, Zoom pivots to AI data platform
Monday, October 26, 2026
This week, I'm excited to dive into stories about Anthropic's partnership with Theorem to verify open-source libraries with Claude, and Zoom's pivot to become an AI data platform. I'm also intrigued by the debate around FDA regulation of generative AI in radiology. These stories highlight the growing importance of AI in various industries and the need for careful consideration of its applications.
— Razi
🔥 Top story
Anthropic partners Theorem to verify 100+ open‑source libs with Claude
Anthropic and Theorem announced a collaboration that uses Claude to formally prove security properties at the assembly level for over 100 real‑world open‑source libraries. The effort aims to catch low‑level bugs that traditional testing misses, leveraging Claude's reasoning to generate proofs automatically. This could raise the baseline security of widely used codebases and set a new standard for LLM‑assisted verification. Developers and security teams should watch for early results and potential integration tools.
Pathos AI raises $237M Series E at $3B valuation to accelerate AI‑driven oncology drugs
Pathos AI announced a $237 million Series E round, pushing its post‑money valuation to $3 billion, up from $1.6 billion a year earlier. The funding will expand its AI platform that designs and optimizes oncology therapeutics, aiming to shorten clinical timelines. For biotech investors and AI drug‑discovery teams, the raise signals strong confidence in AI‑augmented R&D pipelines. Expect accelerated trial launches and potential partnerships with pharma majors.
Zoom pivots from video conferencing to AI data platform
Zoom announced a strategic shift to become an AI data platform, building on its massive video and meeting data assets. The company will offer APIs and tooling for developers to train and deploy generative AI models on Zoom‑generated content. This move positions Zoom against cloud providers and AI‑focused startups, potentially unlocking new revenue streams. Enterprises using Zoom should evaluate upcoming data‑privacy and integration options.
Radiology societies debate FDA regulation of generative AI
Major radiology societies released statements on the FDA's proposed framework to regulate generative AI tools used in imaging. They highlight concerns about safety, validation standards, and the need for clear guidance to avoid stifling innovation. The dialogue will shape how AI diagnostics are approved and deployed in clinical settings. Professionals should monitor upcoming policy drafts for compliance requirements.
Five AI tools receive FDA clearance for prostate cancer MRI detection
The FDA cleared five distinct AI algorithms that assist radiologists in identifying prostate cancer on MRI scans, each demonstrating ≥92% sensitivity in trials. These tools automate lesion detection and risk scoring, aiming to reduce diagnostic variability. For clinicians, the clearances expand the AI‑assisted workflow toolbox and may improve early detection rates. Adoption will depend on integration with existing PACS systems.
U.S. banks tighten third‑party AI agent access controls
Major U.S. banks announced new security policies restricting third‑party AI agents from accessing internal data and transaction systems. The measures respond to rising concerns about model leakage and regulatory scrutiny. Banks will require explicit vendor vetting, audit trails, and real‑time monitoring of AI interactions. This shift may influence fintech partnerships and AI service provisioning across the financial sector.
Claude Duet preview offers proactive AI assistant for professionals
Anthropic released a research preview of Claude Duet, an AI agent that can initiate tasks, monitor progress, and report back without user prompting. Available on web, iOS, and Android for Pro and Max subscribers, Duet integrates with calendars, email, and document tools to automate routine workflows. Early benchmarks show a 30% reduction in time spent on repetitive tasks for pilot users. Professionals should test its integration potential before broader rollout.
Formal verification of assembly code using LLMs gains academic traction
Recent research demonstrates that large language models can generate assembly‑level proofs for safety properties, achieving a 85% success rate on benchmark suites. The approach combines symbolic execution with LLM‑driven conjecture generation, reducing manual proof effort. If adopted, this could accelerate verification pipelines for low‑level systems and embedded devices. The community watches for open‑source toolkits emerging from the work.
This significant investment in Pathos AI demonstrates the confidence in AI-augmented R&D pipelines and may lead to accelerated trial launches and partnerships with pharma majors.
I'm a developer building a secure AI-powered application and I need to verify the security properties of multiple open-source libraries. Using Claude, I want to generate formal proofs for over 100 real-world libraries to ensure their safety and reliability. Can you help me identify the libraries to verify and provide the necessary inputs for Claude to generate the proofs? [library_name], [library_version], [assembly_code].
💡 Tip: To get better results, make sure to provide accurate and up-to-date information about the libraries, including their versions and assembly code, to ensure that Claude can generate reliable proofs.
I've refreshed StarSkirmish Bench, a benchmark where LLMs play StarCraft BW by writing code, with results from the flagship models of OpenAI, Anthropic, Google, and Muse
The paper introduces BizBench, a benchmark that reveals substantial limitations in long-horizon agents, even among frontier models, which struggle with strict success rates and execution validity. This matters to people building with AI because it highlights the need for reliable and constraint-compliant execution in complex business environments. What remains unknown is how BizBench will perform with future models and whether it can be adapted to other high-stakes domains beyond payments.
arXiv · 493 upvotes on Hugging Face Papers · Oct 23
🗳️ Poll
What do you think is the most significant challenge in implementing AI in clinical settings?
A.Ensuring the safety and efficacy of AI-generated results
B.Addressing concerns around model bias and fairness
C.Developing clear guidelines and regulations for AI use in healthcare
D.Integrating AI with existing medical workflows and systems
Vote from your email — results in next week's issue.
MusicGen gives you thirty good seconds at a time. Scoring a 3:20 film means solving the rest — arranging cues against the shot map, stitching them without an audible seam, ducking under narration, and the licence question nobody answers straight.
Have you encountered any challenges in verifying the security properties of open-source libraries using AI tools? If so, please share your experiences and any advice you'd like to offer to others facing similar challenges.
Reply to the email this issue came in to answer.
⚡Quick Bites
• HKEX launches AI and semiconductor market indices
• Retro gaming projects flood the web with AI‑generated ports
• SpaceX and Tesla rumors spark no‑impact commentary
🔥
CV Roaster
Popular
Think your CV is perfect? Let AI prove you wrong in seconds — brutal, honest, and hilarious feedback.
